Xinglu Xu
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Economic Value of Fosaprepitant-Containing Regimen in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China: Cost-Effectiveness and Budget Impact Analysis.
Journal: Frontiers in public health
Published: April 05, 2022
Impact of the National Health Insurance Coverage Policy on the Utilisation and Accessibility of Innovative Anti-cancer Medicines in China: An Interrupted Time-Series Study.
Journal: Frontiers in public health
Published: May 24, 2021
Paricalcitol versus Calcitriol + Cinacalcet for the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease in China: A Cost-Effectiveness Analysis.
Journal: Frontiers in public health
Published: May 19, 2021
Availability, cost and affordability of selected antibiotics and antiviral medicines against infectious diseases from 2013 to 2019 in Nanjing, China.
Journal: Tropical medicine & international health : TM & IH
Published: February 04, 2021
Cost-effectiveness analysis of dacomitinib versus gefitinib for the first-line therapy of patients with EGFR mutation-positive non-small-cell lung cancer in the United States and China.
Journal: Annals of translational medicine
Published: October 19, 2020
The Effects of County Public Hospital Reform on the Consumption and Costs of Antibiotics: Evidence from a Quasinatural Experiment in Jiangsu, China.
Journal: BioMed research international
Published: April 29, 2020
The impact of policy on availability and price of low-price medicines in public healthcare institutions: A retrospective survey in Nanjing, China.
Journal: The International journal of health planning and management
Published: April 05, 2020
Availability, prices and affordability of essential medicines for children: a cross-sectional survey in Jiangsu Province, China.
Journal: BMJ open
Published: October 21, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026